Clinical Trials Browser

Phase 1 × Advance Solid Tumors × Injections × Clear all

NCT07529535 2026-04-17

A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

Phase 1 Suspended

Other solid neoplasm

Advance Solid Tumors